A 58-year-old man with chronic kidney disease (eGFR 32 mL/min/1.73m²) and diabetes mellitus presents for CT angiography of the chest to rule out pulmonary embolism. He is haemodynamically stable and has no prior contrast reactions. What is the most appropriate next step before administering iodinated contrast?

Explanation

## Management of Contrast Administration in CKD Patients **Key Point:** Patients with eGFR <45 mL/min/1.73m² require specific precautions before iodinated contrast administration to minimize contrast-associated acute kidney injury (CA-AKI). ### Pre-Contrast Preparation Protocol **High-Yield:** The standard preventive strategy involves: 1. **Metformin management** — withhold at the time of contrast and for 48 hours post-procedure (risk of lactic acidosis if renal function deteriorates) 2. **Hydration** — isotonic saline (0.9% NaCl) 1 mL/kg/hr for 12 hours before and after contrast 3. **Contrast volume** — minimize to <5 mL/kg body weight 4. **Renal function reassessment** — check creatinine 48–72 hours post-contrast ### Why This Patient Needs Intervention | Risk Factor | Status | Significance | |---|---|---| | eGFR | 32 mL/min/1.73m² | Stage 3b CKD — high CA-AKI risk | | Diabetes | Present | Increases CA-AKI risk 2–3 fold | | Prior contrast reaction | None | Does not eliminate need for renal protection | | Haemodynamic stability | Yes | Allows time for hydration protocol | **Clinical Pearl:** CA-AKI is the third leading cause of acute kidney injury in hospitalised patients. Prevention is far more effective than treatment — even mild renal impairment warrants prophylaxis. **Mnemonic — HYDRATE:** **H**ypertonic saline avoided, **Y**es to isotonic fluids, **D**iabetes = higher risk, **R**enal function baseline, **A**void metformin post-contrast, **T**ime hydration 12 hrs pre/post, **E**GFR <45 = mandatory precautions. ### Why Other Options Fail - **Immediate contrast:** Ignores established CA-AKI prevention guidelines; exposes patient to unnecessary renal injury. - **Gadolinium contrast:** Gadolinium-based agents are contraindicated in CKD (risk of nephrogenic systemic fibrosis, NSF); they do not replace iodinated contrast for CT angiography and are not safer in this context. - **Intradermal sensitivity testing:** No evidence supports this practice; prior absence of reaction does not predict future reactions, and testing delays necessary imaging.